Skin substitutes and uses thereof
AssigneeStratatech Corporation
InventorsPaul Barth Conrad, Cathy Ann-Rusmussen Ivarie, Lynn Allen-Hoffmann
Life of this patent
Estimating the term…
Abstract
The present invention relates to in vitro cultured skin substitutes, and in particular to improved methods for organotypic culture of skin substitutes. In some embodiments, the dermal equivalent of the skin substitute is lifted to air interface of the culture prior to seeding with keratinocytes. In other embodiments, increased concentrations of collagen are used to form the dermal equivalent. In still other embodiments, optimized media are utilized to maintain the skin equivalents.
Claims4
A composition comprising 0.1-10.0 mg/ml bovine serum albumin, 0.1-10.0 μM isoproterenol, 1.0-100.0 μM carnitine, 1.0-100.0 μM serine, 1.0-100.0 μM oleic acid, 1.0-100.0 μM linoleic acid, 1.0-100.0 μM arachidonic acid, 0.1-10.0 μM α-tocopherol, 0.005-5.0 mg/ml ascorbic acid, and 0.1-10.0 ng/ml epiderinal growth factor.
Dependencies are inferred from the claim text.